4
4BB
vs
F
FTSE All Share Index
Over the past 12 months, 4BB has outperformed FTSE All Share Index, delivering a return of -50% compared to the FTSE All Share Index's 0% growth.
Stocks Performance
4BB vs FTSE All Share Index
Performance Gap
4BB vs FTSE All Share Index
Performance By Year
4BB vs FTSE All Share Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
4Basebio PLC
Glance View
4basebio Plc develops gene therapy technologies and solutions. The firm is engaged in developing next generation gene therapy technologies and solutions. The firm is focused on supplying therapeutic deoxyribonucleic (DNA) for gene therapies and DNA vaccines and also for providing solutions for delivery of the DNA based products to patients. The firm focuses to manufacture and supply synthetic DNA for research, therapeutic and pharmacological use. Its TruePrime DNA amplification technology is a primer free DNA amplification method using enzymes. Its Hermes is a non-viral delivery platform that can be used to deliver various payloads, ranging from DNA to small interfering ribonucleic acid (siRNA), as well as protein cargoes. The company also offers a messenger ribonucleic acid (mRNA) production service from the DNA template it makes. The company offers a range of services including production of synthetic DNA and RNA payloads, design and assembly of payloads in nanoparticles.
